Longeveron Inc. (LGVN) NASDAQ
$2.09 (1.44) (-40.79%)
Market Cap: $11.77M
As of 04/17/24 04:00 PM EDT. Market closed.
Longeveron Inc. (LGVN)
NASDAQ
$2.09
(1.44) (-40.79%)
Market Cap: $11.77M
As of 04/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation ... read more
longeveron llc is a leading global regenerative medicine company developing innovative cellular therapeutics for chronic life-threatening diseases. our lead investigational product candidate (lmsc) is based on a specialized cell known as a mesenchymal stem cell that is derived from the bone marrow of healthy young adult donors. our allogeneic, ‘off-the-shelf’ product is under investigation for chronic conditions of the elderly, and other life- threatening diseases, for which no approved therapeutics currently exist: • aging frailty syndrome • alzheimer’s disease • hypoplastic left heart syndrome • the metabolic syndrome read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
26
Address
.
PRICE CHART FOR LONGEVERON INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.47
Previous Close
$3.53
Days Range
$2.60 - $4.24
52 week range
$1.62 - $44
Volume
3,380,408
Avg. Volume (30 days)
6,492,743
Market Cap
$11.77M
Dividend Yield
-
P/E
(0.53)
Shares Outstanding
3,335,297
Open
$2.47
Previous Close
$3.53
Days Range
$2.60 - $4.24
52 week range
$1.62 - $44
Volume
3,380,408
Avg. Volume (30 days)
6,492,743
Market Cap
$11.77M
Dividend Yield
-
P/E
(0.53)
Shares Outstanding
3,335,297
FINANCIAL STATEMENTS FOR LONGEVERON INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR LONGEVERON INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Hare Joshua | Chief Scientific Officer | Apr 11, 2024 | Buy | $2.35 | 42,553 | 100,000 | 633,280 | Apr 12, 2024, 07:00 PM |
| Hare Joshua | Chief Scientific Officer | Apr 10, 2024 | Buy | $2.35 | 106,383 | 250,000 | 590,727 | Apr 12, 2024, 07:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 11, 2024 | Buy | $2.35 | 10,638 | 24,999 | 19,616 | Apr 12, 2024, 07:00 PM |
| Soffer Rock | Director | Apr 11, 2024 | Buy | $2.35 | 31,915 | 75,000 | 208,534 | Apr 12, 2024, 07:00 PM |
| Soffer Rock | Director | Apr 10, 2024 | Buy | $2.35 | 106,383 | 250,000 | 176,619 | Apr 12, 2024, 07:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Mar 12, 2024 | Option Exercise | $0.54 | 32,866 | 17,748 | 89,777 | Mar 20, 2024, 05:00 PM |
| Locklear Lisa | Chief Financial Officer | Jan 02, 2024 | Option Exercise | $1.32 | 4,098 | 5,409 | 36,824 | Jan 25, 2024, 06:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Jan 02, 2024 | Option Exercise | $1.32 | 5,123 | 6,762 | 42,443 | Jan 25, 2024, 06:00 PM |
| Lehr Paul T | General Counsel, Secretary | Jan 02, 2024 | Option Exercise | $1.32 | 992 | 1,309 | 142,406 | Jan 25, 2024, 06:00 PM |
| Agafonova Nataliya | Chief Medical Officer | Jan 02, 2024 | Option Exercise | $1.32 | 3,074 | 4,058 | 20,786 | Jan 25, 2024, 06:00 PM |
| Ross Cathy | Director | Jan 10, 2024 | Buy | $1.31 | 5,000 | 6,544 | 10,000 | Jan 11, 2024, 06:00 PM |
| Baluch Khoso | Director | Dec 29, 2023 | Buy | $1.43 | 8,322 | 11,915 | 15,000 | Jan 02, 2024, 06:00 PM |
| Baluch Khoso | Director | Dec 28, 2023 | Buy | $1.40 | 1,678 | 2,342 | 6,678 | Jan 02, 2024, 06:00 PM |
| PFEFFER JEFFREY | Director | Dec 28, 2023 | Buy | $1.35 | 10,000 | 13,500 | 15,000 | Dec 29, 2023, 05:00 PM |
| Lehr Paul T | General Counsel, Secretary | Oct 02, 2023 | Option Exercise | $2.29 | 815 | 1,866 | 143,398 | Oct 04, 2023, 05:00 PM |
| Locklear Lisa | Chief Financial Officer | Oct 02, 2023 | Option Exercise | $2.29 | 4,078 | 9,339 | 40,922 | Oct 04, 2023, 05:00 PM |
| Agafonova Nataliya | Chief Medical Officer | Oct 02, 2023 | Option Exercise | $2.29 | 3,059 | 7,005 | 23,860 | Oct 04, 2023, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Sep 21, 2023 | Option Exercise | $3.00 | 5,000 | 15,000 | 7,828,263 | Sep 22, 2023, 07:00 PM |
| Lehr Paul T | General Counsel, Secretary | Sep 20, 2023 | Option Exercise | $3.00 | 2,000 | 6,000 | 144,213 | Sep 21, 2023, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Sep 12, 2023 | Option Exercise | $3.00 | 30,000 | 90,000 | 7,823,263 | Sep 14, 2023, 05:09 PM |
| Locklear Lisa | Chief Financial Officer | Sep 12, 2023 | Option Exercise | $3.00 | 5,000 | 15,000 | 45,000 | Sep 13, 2023, 05:55 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sep 12, 2023 | Option Exercise | $3.00 | 10,000 | 30,000 | 47,566 | Sep 13, 2023, 05:00 PM |
| Soffer Rock | Director | Sep 08, 2023 | Option Exercise | $3.00 | 30,000 | 90,000 | 702,351 | Sep 12, 2023, 05:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Sep 01, 2023 | Option Exercise | $2.64 | 4,323 | 11,413 | 37,566 | Sep 06, 2023, 05:00 PM |
| Lehr Paul T | General Counsel, Secretary | Aug 18, 2023 | Option Exercise | $3.25 | 767 | 2,493 | 142,213 | Aug 22, 2023, 05:00 PM |
| Agafonova Nataliya | Chief Medical Officer | Aug 18, 2023 | Option Exercise | $3.36 | 3,081 | 10,352 | 26,919 | Aug 22, 2023, 05:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Aug 18, 2023 | Option Exercise | $3.25 | 4,292 | 13,949 | 41,889 | Aug 22, 2023, 05:00 PM |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 05, 2023 | Option Exercise | $2.61 | 3,819 | 9,968 | 46,181 | Jul 17, 2023, 05:48 PM |
| Clavijo James | CFO and Treasurer | Jun 28, 2023 | Sale | $3.43 | 10,000 | 34,300 | 52,303 | Jun 29, 2023, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jun 27, 2023 | Sale | $3.48 | 8,532 | 29,691 | 62,303 | Jun 29, 2023, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jun 29, 2023 | Sale | $3.51 | 5,000 | 17,550 | 47,303 | Jun 29, 2023, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jun 02, 2023 | Option Exercise | $3.42 | 752 | 2,572 | 70,835 | Jun 12, 2023, 05:15 PM |
| Lehr Paul T | General Counsel, Secretary | Jun 02, 2023 | Option Exercise | $3.25 | 3,247 | 10,553 | 142,980 | Jun 09, 2023, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jun 02, 2023 | Option Exercise | $3.25 | 3,247 | 10,553 | 71,587 | Jun 09, 2023, 05:00 PM |
| Lehr Paul T | General Counsel, Secretary | Apr 03, 2023 | Option Exercise | $2.61 | 815 | 2,127 | 146,227 | Apr 05, 2023, 04:59 PM |
| Clavijo James | CFO and Treasurer | Apr 03, 2023 | Option Exercise | $2.61 | 815 | 2,127 | 74,834 | Apr 05, 2023, 04:58 PM |
| Hare Joshua | Chief Scientific Officer | Jan 27, 2023 | Sale | $4.28 | 20,000 | 85,600 | 7,793,263 | Jan 30, 2023, 05:00 PM |
| Lehr Paul T | General Counsel, Secretary | Jan 03, 2023 | Option Exercise | $3.37 | 1,472 | 4,961 | 147,042 | Jan 04, 2023, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jan 03, 2023 | Option Exercise | $3.37 | 1,288 | 4,341 | 75,649 | Jan 04, 2023, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Dec 02, 2022 | Sale | $3.74 | 20,000 | 74,800 | 7,813,263 | Dec 05, 2022, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Oct 12, 2022 | Sale | $3.61 | 100,000 | 361,000 | 7,813,263 | Oct 18, 2022, 05:01 PM |
| Clavijo James | CFO and Treasurer | Oct 03, 2022 | Option Exercise | $3.75 | 1,256 | 4,710 | 76,937 | Oct 05, 2022, 05:01 PM |
| Lehr Paul T | General Counsel, Secretary | Oct 03, 2022 | Option Exercise | $3.75 | 1,435 | 5,381 | 148,514 | Oct 05, 2022, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jul 01, 2022 | Option Exercise | $5.94 | 1,426 | 8,470 | 78,193 | Jul 05, 2022, 05:01 PM |
| Lehr Paul T | General Counsel, Secretary | Jul 01, 2022 | Option Exercise | $5.94 | 1,629 | 9,676 | 149,949 | Jul 05, 2022, 05:00 PM |
| Clavijo James | CFO and Treasurer | Jun 03, 2022 | Sale | $8.26 | 36,955 | 305,248 | 79,619 | Jun 07, 2022, 05:00 PM |
| Soffer Rock | Director | May 20, 2022 | Sale | $8.06 | 7,500 | 60,435 | 684,351 | May 24, 2022, 05:14 PM |
| Soffer Rock | Director | May 24, 2022 | Sale | $7.50 | 4,000 | 30,000 | 672,351 | May 24, 2022, 05:14 PM |
| Soffer Rock | Director | May 23, 2022 | Sale | $7.78 | 8,000 | 62,200 | 676,351 | May 24, 2022, 05:14 PM |
| Hare Joshua | Chief Scientific Officer | Apr 19, 2022 | Sale | $10.00 | 78 | 780 | 7,913,263 | Apr 20, 2022, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Apr 18, 2022 | Sale | $10.00 | 19,922 | 199,290 | 7,913,341 | Apr 20, 2022, 05:00 PM |
| Lehr Paul T | General Counsel, Secretary | Apr 04, 2022 | Option Exercise | $15.61 | 1,472 | 22,978 | 111,578 | Apr 08, 2022, 05:00 PM |
| Green Geoff | CEO | Apr 04, 2022 | Option Exercise | $15.61 | 1,840 | 28,722 | 133,904 | Apr 08, 2022, 05:00 PM |
| Hare Joshua | Chief Scientific Officer | Oct 12, 2021 | Buy | $3.69 | 2,500 | 9,225 | 7,933,263 | Oct 14, 2021, 09:00 AM |
| Green Geoff | CEO | Oct 13, 2021 | Buy | $3.81 | 1,000 | 3,810 | 139,723 | Oct 14, 2021, 09:00 AM |
| Soffer Rock | Director | Oct 13, 2021 | Buy | $3.76 | 12,000 | 45,120 | 51,757 | Oct 13, 2021, 06:00 PM |
| Soffer Rock | Director | Oct 12, 2021 | Buy | $3.57 | 4,000 | 14,280 | 39,757 | Oct 13, 2021, 06:00 PM |
| Soffer Rock | Director | Oct 11, 2021 | Buy | $3.45 | 3,900 | 13,455 | 35,757 | Oct 13, 2021, 06:00 PM |
| Clavijo James | CFO and Treasurer | Oct 07, 2021 | Buy | $3.34 | 5,000 | 16,700 | 79,598 | Oct 12, 2021, 09:30 AM |
| Lehr Paul T | General Counsel, Secretary | Oct 07, 2021 | Buy | $3.34 | 1,750 | 5,845 | 116,366 | Oct 12, 2021, 09:30 AM |
| Hare Joshua | Chief Scientific Officer | Oct 08, 2021 | Buy | $3.39 | 3,015 | 10,221 | 7,930,763 | Oct 12, 2021, 09:30 AM |
| Hare Joshua | Chief Scientific Officer | Oct 07, 2021 | Buy | $3.38 | 1,985 | 6,709 | 7,927,748 | Oct 12, 2021, 09:30 AM |
| Lehr Paul T | General Counsel, Secretary | Oct 01, 2021 | Option Exercise | $3.65 | 38,752 | 141,445 | 114,616 | Oct 01, 2021, 08:01 PM |
| Clavijo James | CFO and Treasurer | Oct 01, 2021 | Option Exercise | $3.65 | 19,052 | 69,540 | 74,598 | Oct 01, 2021, 08:00 PM |
| Green Geoff | CEO | Oct 01, 2021 | Option Exercise | $3.65 | 43,929 | 160,341 | 138,723 | Oct 01, 2021, 08:00 PM |
| Hare Joshua | Chief Scientific Officer | Feb 12, 2021 | Buy | $10.00 | 12,000 | 120,000 | 7,908,428 | Apr 09, 2021, 04:03 PM |
| Soffer Rock | Director | Feb 12, 2021 | Buy | $8.05 | 100 | 805 | 26,857 | Feb 26, 2021, 06:00 PM |
| Soffer Donald M | Director | Feb 12, 2021 | Buy | $10.00 | 100,000 | 1,000,000 | 153,514 | Feb 26, 2021, 06:00 PM |
| Hare Joshua | Chief Scientific Officer | Feb 12, 2021 | Buy | $9.98 | 103,000 | 1,028,230 | 7,998,428 | Feb 17, 2021, 04:30 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Hare Joshua | Chief Scientific Officer | 04/11/2024 | 100,000 |
| Hare Joshua | Chief Scientific Officer | 04/10/2024 | 250,000 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 04/11/2024 | 24,999 |
| Soffer Rock | Director | 04/11/2024 | 75,000 |
| Soffer Rock | Director | 04/10/2024 | 250,000 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 03/12/2024 | 17,748 |
| Locklear Lisa | Chief Financial Officer | 01/02/2024 | 5,409 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 01/02/2024 | 6,762 |
| Lehr Paul T | General Counsel, Secretary | 01/02/2024 | 1,309 |
| Agafonova Nataliya | Chief Medical Officer | 01/02/2024 | 4,058 |
| Ross Cathy | Director | 01/10/2024 | 6,544 |
| Baluch Khoso | Director | 12/29/2023 | 11,915 |
| Baluch Khoso | Director | 12/28/2023 | 2,342 |
| PFEFFER JEFFREY | Director | 12/28/2023 | 13,500 |
| Lehr Paul T | General Counsel, Secretary | 10/02/2023 | 1,866 |
| Locklear Lisa | Chief Financial Officer | 10/02/2023 | 9,339 |
| Agafonova Nataliya | Chief Medical Officer | 10/02/2023 | 7,005 |
| Hare Joshua | Chief Scientific Officer | 09/21/2023 | 15,000 |
| Lehr Paul T | General Counsel, Secretary | 09/20/2023 | 6,000 |
| Hare Joshua | Chief Scientific Officer | 09/12/2023 | 90,000 |
| Locklear Lisa | Chief Financial Officer | 09/12/2023 | 15,000 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 09/12/2023 | 30,000 |
| Soffer Rock | Director | 09/08/2023 | 90,000 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 09/01/2023 | 11,413 |
| Lehr Paul T | General Counsel, Secretary | 08/18/2023 | 2,493 |
| Agafonova Nataliya | Chief Medical Officer | 08/18/2023 | 10,352 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 08/18/2023 | 13,949 |
| Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | 04/05/2023 | 9,968 |
| Clavijo James | CFO and Treasurer | 06/28/2023 | 34,300 |
| Clavijo James | CFO and Treasurer | 06/27/2023 | 29,691 |
| Clavijo James | CFO and Treasurer | 06/29/2023 | 17,550 |
| Clavijo James | CFO and Treasurer | 06/02/2023 | 2,572 |
| Lehr Paul T | General Counsel, Secretary | 06/02/2023 | 10,553 |
| Clavijo James | CFO and Treasurer | 06/02/2023 | 10,553 |
| Lehr Paul T | General Counsel, Secretary | 04/03/2023 | 2,127 |
| Clavijo James | CFO and Treasurer | 04/03/2023 | 2,127 |
| Hare Joshua | Chief Scientific Officer | 01/27/2023 | 85,600 |
| Lehr Paul T | General Counsel, Secretary | 01/03/2023 | 4,961 |
| Clavijo James | CFO and Treasurer | 01/03/2023 | 4,341 |
| Hare Joshua | Chief Scientific Officer | 12/02/2022 | 74,800 |
| Hare Joshua | Chief Scientific Officer | 10/12/2022 | 361,000 |
| Clavijo James | CFO and Treasurer | 10/03/2022 | 4,710 |
| Lehr Paul T | General Counsel, Secretary | 10/03/2022 | 5,381 |
| Clavijo James | CFO and Treasurer | 07/01/2022 | 8,470 |
| Lehr Paul T | General Counsel, Secretary | 07/01/2022 | 9,676 |
| Clavijo James | CFO and Treasurer | 06/03/2022 | 305,248 |
| Soffer Rock | Director | 05/20/2022 | 60,435 |
| Soffer Rock | Director | 05/24/2022 | 30,000 |
| Soffer Rock | Director | 05/23/2022 | 62,200 |
| Hare Joshua | Chief Scientific Officer | 04/19/2022 | 780 |
| Hare Joshua | Chief Scientific Officer | 04/18/2022 | 199,290 |
| Lehr Paul T | General Counsel, Secretary | 04/04/2022 | 22,978 |
| Green Geoff | CEO | 04/04/2022 | 28,722 |
| Hare Joshua | Chief Scientific Officer | 10/12/2021 | 9,225 |
| Green Geoff | CEO | 10/13/2021 | 3,810 |
| Soffer Rock | Director | 10/13/2021 | 45,120 |
| Soffer Rock | Director | 10/12/2021 | 14,280 |
| Soffer Rock | Director | 10/11/2021 | 13,455 |
| Clavijo James | CFO and Treasurer | 10/07/2021 | 16,700 |
| Lehr Paul T | General Counsel, Secretary | 10/07/2021 | 5,845 |
| Hare Joshua | Chief Scientific Officer | 10/08/2021 | 10,221 |
| Hare Joshua | Chief Scientific Officer | 10/07/2021 | 6,709 |
| Lehr Paul T | General Counsel, Secretary | 10/01/2021 | 141,445 |
| Clavijo James | CFO and Treasurer | 10/01/2021 | 69,540 |
| Green Geoff | CEO | 10/01/2021 | 160,341 |
| Hare Joshua | Chief Scientific Officer | 02/12/2021 | 120,000 |
| Soffer Rock | Director | 02/12/2021 | 805 |
| Soffer Donald M | Director | 02/12/2021 | 1,000,000 |
| Hare Joshua | Chief Scientific Officer | 02/12/2021 | 1,028,230 |
Load More Insider Transactions
FUNDS WITH A POSITION IN LONGEVERON INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 111,700 | 0% | -0.12% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 90,238 | 0.00001% | 22.82% | Other |
CHANGE IN SHARES OUTSTANDING FOR LONGEVERON INC
STOCK BUYBACKS FOR LONGEVERON INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
11.53%
1Q
06/30/2023
11.92%
2Q
03/31/2023
12.30%
3Q
12/31/2022
12.38%
4Q
09/30/2022
12.47%
5Q
06/30/2022
12.78%
6Q
03/31/2022
12.95%
7Q
12/31/2021
17.92%
8Q
09/30/2021
23.57%
9Q
06/30/2021
24.28%
10Q
03/31/2021
35.04%
11Q
12/31/2020
47.25%
12Q
09/30/2020
47.25%
13Q
06/30/2020
47.90%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR LONGEVERON INC
LOADING...